Synaesthesia and autism are two neurodevelopmental conditions that have been shown to co-occur more than expected by chance. The studies reported here test the hypothesis that increased sensory sensitivity and enhanced Attention-to-detail are core cognitive features that are shared between them. In Study 1, we administer self-report measures of sensory sensitivity and autistic traits (the Autism Spectrum Quotient, AQ) to a large heterogeneous sample of synaesthetes. Both sensory sensitivity and the Attention-to-detail subscale of the AQ show a "dose-like" relationship with synaesthesia: namely, more kinds of synaesthesia is related to a greater shift up the autistic spectrum. Study 2 uses two objective measures of visual perception/attention linked to autistic traits: Change Blindness and detection of local embedded figures. Both measures are shown here to be sensitive to the Attention-to-detail subscale of the AQ, and synaesthetes outperformed controls on both tasks. Synaesthetes appear to occupy a specific cognitive niche of having autistic-like traits linked to enhanced perception and attention. Whilst these typically occur in the absence of the traditional impairments that define autism, they may carry the cost of increased vulnerability to clinical levels of autism (Odds Ratio ¼ 2.07).
Introduction
Synaesthesia and autism are two relatively common neurodevelopmental conditions that emerge early in life (Baird et al., 2006; Simner, Harrold, Creed, Monro, & Foulkes, 2009) and have a genetic contribution (Ma et al., 2009; Tomson et al., 2011) . Several recent studies have shown that they are related insofar as the two conditions co-occur more often than expected by chance (Baron-Cohen et al., 2013; Neufeld et al., 2013) . Baron-Cohen et al. (2013) reported a prevalence of 18.9% for various kinds of synaesthesia in their highfunctioning autism sample, relative to 7.2% in their controls (Odds ratio ¼ 2.997, 95% CI ¼ 1.265e7.101). Neufeld et al. (2013) reported a prevalence of 17.2% of grapheme-colour synaesthesia (GCS) in their high-functioning autism sample (they didn't test a separate control group but relied on published norms of 1.1e2.0% for this kind of synaesthesia and 4.6% if including other kinds; Simner et al., 2006) . This co-morbidity may reflect shared features of atypical brain development in these groups, for instance regarding brain connectivity. The present research tackles the issue as to how/why they are
